Ferozsons Laboratories Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	841.51	692.53	551.06	569.05	415.83	830.51
Short-Term Investments	2,116	-	-	-	-	-
Trading Asset Securities	-	1,661	496.5	544.97	2,036	1,940
Cash & Short-Term Investments	2,958	2,354	1,048	1,114	2,452	2,771
Cash Growth	-44.29%	124.67%	-5.96%	-54.57%	-11.51%	203.81%
Accounts Receivable	2,992	2,301	2,417	1,123	1,140	1,540
Other Receivables	188.28	285.31	283.81	259.9	432.11	23.37
Receivables	3,181	2,587	2,700	1,383	1,572	1,563
Inventory	8,005	6,806	4,978	5,196	3,260	2,107
Prepaid Expenses	-	28.72	11.84	7.05	1.15	0.42
Other Current Assets	961.26	1,123	1,046	833	468.26	629.81
Total Current Assets	15,105	12,898	9,783	8,533	7,754	7,071
Property, Plant & Equipment	11,398	11,557	11,828	7,975	6,113	4,792
Other Intangible Assets	13.22	27.63	41.04	1.55	1	0.64
Other Long-Term Assets	239.98	122.21	96.98	93.92	93.92	93.92
Total Assets	26,756	24,605	21,750	16,603	13,962	11,958
Accounts Payable	5,343	1,931	1,125	2,716	1,657	1,354
Accrued Expenses	74.56	1,017	897.6	539.82	611.89	615.99
Short-Term Debt	2,196	2,248	2,743	1,261	492.52	-
Current Portion of Long-Term Debt	407.38	395.74	333.07	379.88	141.69	181.53
Current Unearned Revenue	427.25	469.33	471.27	251.96	200.95	79.89
Other Current Liabilities	105.08	590.94	514.79	343.17	282.76	287.6
Total Current Liabilities	8,553	6,652	6,085	5,491	3,387	2,519
Long-Term Debt	1,451	1,648	1,844	1,841	1,537	957.1
Long-Term Unearned Revenue	292.93	351.55	476.91	531.88	331.33	174.13
Long-Term Deferred Tax Liabilities	1,500	1,487	1,524	375.36	408.64	415.23
Total Liabilities	11,797	10,138	9,929	8,240	5,664	4,066
Common Stock	434.69	434.69	434.69	434.69	362.24	362.24
Retained Earnings	8,856	8,396	7,040	6,290	6,100	5,713
Comprehensive Income & Other	3,439	3,544	3,754	1,193	1,305	1,398
Total Common Equity	12,729	12,375	11,228	7,918	7,768	7,473
Minority Interest	2,230	2,091	591.88	445.45	530.68	419.17
Shareholders' Equity	14,959	14,467	11,820	8,364	8,298	7,892
Total Liabilities & Equity	26,756	24,605	21,750	16,603	13,962	11,958
Total Debt	4,054	4,292	4,920	3,482	2,171	1,139
Net Cash (Debt)	-1,096	-1,938	-3,872	-2,368	280.9	1,632
Net Cash Growth	-	-	-	-	-82.79%	121.28%
Net Cash Per Share	-25.22	-44.59	-89.08	-54.47	6.46	37.55
Filing Date Shares Outstanding	43.47	43.47	43.47	43.47	43.47	43.47
Total Common Shares Outstanding	43.47	43.47	43.47	43.47	43.47	43.47
Working Capital	6,553	6,246	3,698	3,042	4,367	4,552
Book Value Per Share	292.83	284.69	258.31	182.16	178.70	171.92
Tangible Book Value	12,716	12,348	11,187	7,917	7,767	7,473
Tangible Book Value Per Share	292.53	284.05	257.36	182.12	178.67	171.91
Land	-	1,691	1,691	849.15	849.15	849.15
Buildings	-	2,793	2,013	1,117	1,048	1,028
Machinery	-	8,413	5,077	3,363	2,980	2,660
Construction In Progress	-	168.56	3,708	4,160	2,337	1,011

Source: S&P Global Market Intelligence. Standard template. Financial Sources.